A specialist from Oman, located at the crossroads of Africa and Asia, explains that his nation serves as a microcosm when it ...

Zydus Lifesciences announced a significant development for beta-thalassemia patients. The US Food and Drug Administration has ...

Vertex Pharmaceuticals Inc. reported third-quarter sales that beat analysts’ expectations as the biotech company’s mainstay ...

Vertex Pharmaceuticals reported on Monday that it beat Wall Street estimates for third-quarter results, driven by strong demand for its cystic fibrosis treatments and early contributions from newer ...

said Joanne Lager, MD, Chief Medical Officer. "The presentation highlights the growing demand for ZYNTEGLO, the first FDA-approved gene therapy for eligible patients with transfusion-dependent ...

A new research project at the Cyprus Institute of Neurology and Genetics (CING) aims to develop a one-time, curative therapy for beta-thalassaemia, the most common inherited blood disorder in Cyprus.

Abstract: Deep learning technology has made significant strides in diagnosing various diseases. One of the most crucial factors is selecting the appropriate hyperparameter combination, which can ...

We may earn a commission when you click links to retailers and purchase goods. More info. Google just released the Android 16 QPR2 Beta 3 update for all of its still-supported Pixel devices, including ...

iOS 26.1 continues to be refined and expanded ahead of its wide public launch. Today’s public beta 3 includes the standard bug fixes and performance improvements that are typical in later-stage betas.

Apple's beta cycle for iOS 26.1 continues with the arrival of iOS 26.1 beta 3 for developers. Alongside the third version of the iPhone's upcoming operating system update, Apple also seeded beta 3 of ...